Polymicrobial biofilms, consisting of fungal and bacterial pathogens, often contribute to the
failure of antimicrobial treatment. The growing resistance of pathogenic polymicrobial …

The co-isolation of Staphylococcus aureus and Candida albicans from host tissues and
organs and their in vitro and in vivo interaction studies suggest a synergistic relationship in …

The virulence and drug resistance of globally prevalent Candida albicans has presented
complications toward its control while advances in effective antivirulence drugs remain …

The polymicrobial proliferation and development of complex biofilm morphologies by
bacterial and fungal pathogens in the host are some of the key factors contributing to the …

Over decades bacteria have evolved multiple mechanisms to fight antibiotics. Biofilm
formation by bacteria is one such mechanism as it forms a barrier and creates an acidic …

Background: Biofilm formation by Candida albicans is a significant clinical challenge. Fungal
biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B …

Biofilm formation is one of the major problems associated with chronic diseases and also
attributes for the antibiotic resistance in bacteria. In recent times nanoparticles have been …

Biofilms are microbial colonies that are encased in an organic polymeric matrix and are
resistant to antimicrobial treatments. Biofilms can adhere to both biotic and abiotic surfaces …

The formation of biofilms by bacterial pathogens and the presence of persister cells in
biofilms have become major concerns in the health sector, owing to their antibiotic …

Owing to the growing infectious diseases caused by eukaryotic and prokaryotic pathogens, it
is urgent to develop novel antimicrobial agents against clinical pathogenic infections. Biofilm …